Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study

Objectives The objective of this study is to compare the early oncological outcomes of delayed (>90 days) versus scheduled (≤90 days) radical prostatectomy (RP). Patients and methods Patients with prostate cancer due to undergo surgery between March 2020 and June 2020 who were enrolled in the COV...

Full description

Saved in:
Bibliographic Details
Published in:BJUI compass 2024-12, Vol.5 (12), p.1314-1323
Main Authors: Nathan, Arjun, Gao, Chuanyu, Light, Alexander, Alexander, Cameron, Chan, Vinson, Gallagher, Kevin, Khadhouri, Sinan, Byrnes, Kevin G., Ng, Michael, Walters, Michael, Hughes, Terry, Perry, Rita J., Okoth, Kelvin, Magill, Laura, Pinkney, Thomas, Zhang, Yuhao, Blackmur, James, Etchill, Eric, Tang, Stanley, García Escudero, Damián, McNeill, Alan, Narahari, Krishna, Stewart, Grant D., Kasivisvanathan, Veeru
Format: Article
Language:English
Subjects:
Cancer
COVID
delay
Original
prostate cancer
radical prostatectomy
Surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The objective of this study is to compare the early oncological outcomes of delayed (>90 days) versus scheduled (≤90 days) radical prostatectomy (RP). Patients and methods Patients with prostate cancer due to undergo surgery between March 2020 and June 2020 who were enrolled in the COVIDSurg‐Cancer international, observational study were prospectively followed up for 1 year. Time to surgery was defined as the difference between the operation date and the multi‐disciplinary team decision to offer surgery. The primary outcome was the positive surgical margin (PSM) rate. Biochemical recurrence (BCR), upgradation and upstaging were secondary oncological outcomes. The Independent t‐test and Mann Whitney U test were used to compare means between groups and regression models and were used to investigate factors associated with the primary outcome. Results Four hundred seventy‐six (78.7%) patients underwent RP from 605 that were eligible. Three hundred seven (64.5%) patients underwent scheduled RP, and 169 (35.5%) underwent delayed RP. A small proportion of men (n = 35, 6.8%) did not undergo RP within the 1‐year follow‐up period. More men with high‐risk disease (72.8%) underwent scheduled RP compared to men with intermediate‐risk disease (60.2%) (p 
ISSN:2688-4526
2688-4526
DOI:10.1002/bco2.433